GlassScriptPhysician profile
Fabio Vasconcelos Lima
NPI 1669829974
$29,572.76
in general payments reported to CMS, 2019-2025
27 companies · $2,632 in 2025
The $2,632 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $278 · 2021: $856 · 2022: $4,266 · 2023: $14K · 2024: $7,736 · 2025: $2,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,590 · Food and Beverage: $7,683 · Grant: $6,000 · Consulting Fee: $530 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,589.77 |
| Food and Beverage | $7,682.93 |
| Grant | $6,000.00 |
| Consulting Fee | $530.00 |
| Education | $196.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,331.86 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Abre |
| Edwards Lifesciences Corporation | $9,555.75 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,534.36 | 2020-2025 | Mitraclip, Navitor |
| Medical Device Business Services, INC. | $1,105.24 | 2023 | Carto 3 |
| W. L. Gore & Associates, INC. | $1,029.23 | 2024 | Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $1,014.03 | 2022-2024 | Sentinel |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $777.17 | 2019-2025 | Lifevest |
| Abiomed | $586.49 | 2022-2025 | Impella |
| Angiodynamics, INC. | $378.73 | 2023-2024 | Alphavac, Angiovac |
| Penumbra, INC. | $374.33 | 2022-2023 | Indigo System |
| Heartflow, INC. | $256.23 | 2023 | Ffrct |
| Shockwave Medical, INC | $246.57 | 2025 | |
| Amgen INC. | $233.59 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $199.45 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $192.68 | 2024-2025 | Camzyos, Eliquis |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.61 | 2024-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $122.18 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $94.11 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $84.08 | 2025 | Onpattro |
| Inari Medical, INC. | $71.23 | 2021 | |
| Esperion Therapeutics, INC. | $41.90 | 2025 | Nexletol |
| Biosense Webster, INC. | $25.05 | 2025 | Nuvision Ice Catheter |
| Scpharmaceuticals INC. | $19.93 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.95 | 2024 | Wainua |
| Philips North America LLC | $16.45 | 2024 | (Ck7) Extended Holter |
| Cvrx, INC. | $15.22 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabio Lima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.